CTEV EPS Growth
58.44%TTM
Period ending:
CTEV TTM EPS YoY %%
348.07%-1909.71%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
CTEV eps growth history
Year-over-year earnings per share growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | EPS Growth |
|---|---|
| 58.4412% | |
| 76.2277% | |
| 83.0259% | |
| 78.0779% | |
| 43.6405% | |
| -86.4302% | |
| -1,691.2127% | |
| -114.7934% | |
| -74.0856% | |
| -1.1543% | |
| 84.1372% | |
| -787.4133% | |
| -514.6809% | |
| -704.0141% | |
| -660.4687% | |
| 129.571% | |
| 124.3373% | |
| 115.483% | |
| 114.4698% |
Compare eps growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) eps growth
- Ensign Group Inc (ENSG) eps growth
- Krystal Biotech Inc (KRYS) eps growth
- Protagonist Therapeutics Inc (PTGX) eps growth
- Tg Therapeutics Inc (TGTX) eps growth
- Healthequity Inc (HQY) eps growth
- Pacs Group Inc (PACS) eps growth
- Alkermes (ALKS) eps growth
Compare all covered stocks by eps growth →
All CTEV financial metrics · CTEV stock overview · How to interpret financial metrics
